Study of Bacopa in Gulf War Illness Patients
Part of paid clinical trials in Davie, Florida.
- Sponsor
- Nova Southeastern University
- Study ID
- NCT04927338
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Gulf War Illness
Eligibility Criteria
- Sex
- ALL
- Age
- 46 Years - 78 Years
- Healthy Volunteers
- Not accepted
Interventions
- BacoMind® (Bacopa monnieri standardized extract) — DIETARY_SUPPLEMENTBacoMind® (Bacopa monnieri standardized extract) 300 mg daily capsule.
- Placebo — DRUGDaily placebo capsule identical in size, color, and shape to that of the Bacopa capsules.
Study Details
Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase II, double masked, randomized, placebo-controlled, two-arm study will evaluate cognitive function as evidence of efficacy of the nutraceutical intervention, Bacopa, on central nervous system symptom management of Gulf War Illness, along with assessments of safety of the intervention.
Key Dates
- Start date
- Dec 1, 2022
- Status verified
- Jul 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 170 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: BacoMind® 300mg/dayParticipants randomized to the experimental arm will receive 12 weeks of 300 mg/day BacoMind® Bacopa monnieri standardized extract.
- Placebo Comparator: PlaceboParticipants randomized to the placebo arm will receive 12 weeks of daily placebo identical to the experimental treatment in size, color, and shape.
Primary Outcome Measure
California Verbal Learning Test (CVLT-II) Assessment [ Time Frame: 12 weeks ]
Central Contacts
- Mayra Vidro, MPH954-262-2841
- Karen Kesler, PhD919-485-1429
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nova Southeastern University | Davie | Florida | 33314 | Amanpreet Cheema, PhD (PRINCIPAL_INVESTIGATOR) Nancy Klimas, MD (SUB_INVESTIGATOR) Kristina Aenlle, PhD (SUB_INVESTIGATOR) |
Find similar trials in Davie, FL
By research site
Related Studies
- Nicotinamide Riboside Clinical Trial for GWIRecruiting · Roskamp Institute Inc. · Fort Lauderdale, Florida
- Ca-Mg Butyrate in GWIPHASE2 · Recruiting · VA Office of Research and Development · Long Beach, California
- Confirmation of Diet as a Treatment for Gulf War IllnessPHASE3 · Recruiting · American University · Washington D.C., District of Columbia
- Validating Gulf War Illness Blood BiomarkersRecruiting · Roskamp Institute Inc. · Palo Alto, California